The FDA has liberated the second of two Intellia Therapeutics clinical trials that were put on hold last October following serious liver toxicity.
Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula
The FDA has liberated the second of two Intellia Therapeutics clinical trials that were put on hold last October following serious liver toxicity.